TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/30/2024
Back to search
Official data from USPTO
SK BIOPHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
12/30/2024
Trademark type
Combined
Nice classes
5
Filing date
10/24/2022
Registration date
02/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2024
Last transaction
12/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Seoul, KR
Examiner
KIM, ERICA
Law office
O40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "SK" in red stylized font to the left of the letters "BIOPHARMACEUTICALS" in orange stylized font. To the top right of the "SK" portion of the mark is a design of wings. The inner portion of the wings is red, and the outer portion of the wings is orange. White is not claimed as a feature of the mark and only represents background or transparent areas.
Holders and representatives
Holders
SK Inc.
Representatives
Hun Joon Kim LEX IP Meister, PLLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary pharmaceutical preparations for treatment of central nervous system diseasescancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; biochemical preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for pharmaceutical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; medical preparation of trace elements for human and animal usefor the treatment of central nervous system diseasescancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; blood solventblood plasma; chemical preparations for medicinal purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for medical or veterinary purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drug delivery agents in the form of dissolvable filmscoatings for tabletsthat facilitate the delivery of pharmaceutical preparations for the treatment of central nervous system diseasescancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseasescancer and metabolic diseases; bacteriological preparations for medical and veterinary use
Publications
History of USPTO decisions and trademark events.
23 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/30/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
12/30/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/30/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/30/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/13/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2023
PUBO
PUBLISHED FOR OPPOSITION
11/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
10/24/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
10/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/24/2023
GNRT
NON-FINAL ACTION E-MAILED
07/24/2023
CNRT
NON-FINAL ACTION WRITTEN
07/24/2023
DOCK
ASSIGNED TO EXAMINER
07/06/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2022
NWAP
NEW APPLICATION ENTERED
10/27/2022
Continuous trademark protection
Get notified about every new filing that threatens SK BIOPHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.